ERBB2 and neoplasm: The pretheraputic serum levels of Her-2/neu were significantly elevated in patients with large tumour size (P<0.005) and showed a significant inverse correlation between serum Her-2/neu and hormone receptor status (r=-0.45, P<0.05).